(Reuters) – The coronavirus variant first identified in Brazil, known as P.1, is resistant to three of the four antibody therapies with emergency use authorization in the United States, according...

A big change in drug treatment for cancer is arriving in Georgia. It’s not a new medication. What’s coming is something known as “white bagging,” an insurer tactic involving...

This is the third in a series of articles on delivering cancer treatment at home. If providing cancer therapies at home means handing off patients to a home-infusion company, Tennessee Oncology wants...

Rituximab, an anti-cancer drug targeting the membrane protein CD20, was the first approved therapeutic antibody against B tumor cells. Immunologists at the University of Freiburg have now solved a mystery...

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MABTHERA IV NHL AND CLL 160310 For the treatment of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic...